UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 225

Sortiert nach

Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery

Pharmaceutics, 2023-02, Vol.15 (2), p.547

2023

Volltextzugriff (PDF)

An emerging terpolymeric nanoparticle pore former as an internal recrystallization inhibitor of celecoxib in controlled release amorphous solid dispersion beads: Experimental studies and molecular dynamics analysis

Acta pharmaceutica Sinica. B, 2024-06, Vol.14 (6), p.2669-2684

2024

Volltextzugriff (PDF)

A Quality-by-Design Study for an Immediate-Release Tablet Platform: Examining the Relative Impact of Active Pharmaceutical Ingredient Properties, Processing Methods, and Excipient Variability on Drug Product Quality Attributes

Journal of pharmaceutical sciences, 2014-02, Vol.103 (2), p.527-538

2014

Volltextzugriff (PDF)

Key parameters to be optimized in the development and manufacturing of oral solid-dosage forms

Pharmaceutical technology Europe, 2017-04, Vol.29 (4), p.14

Kane, Anil

2017

Volltextzugriff (PDF)

Phase-Appropriate Formulation and Process Design

Pharmaceutical technology Europe, 2016-01, Vol.28 (1), p.22

Kane, Anil

2016

Volltextzugriff (PDF)

Phase-appropriate formulation and process design: appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development

Pharmaceutical technology Europe, 2016-01, p.22

Kane, Anil

2016

Volltextzugriff (PDF)

Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: Effect of dosage form design

European journal of pharmaceutical sciences, 2018-11, Vol.124, p.319-327

2018

Volltextzugriff (PDF)

Tailoring Release Profiles of BCS Class II Drugs Using Controlled Release Amorphous Solid Dispersion Beads with Membrane-Reservoir Design: Effect of Pore Former and Coating Levels

Molecular pharmaceutics, 2021-11, Vol.18 (11), p.4198-4209

2021

Volltextzugriff (PDF)

Investigation of a new pH-responsive nanoparticulate pore former for controlled release enteric coating with improved processability and stability

European journal of pharmaceutics and biopharmaceutics, 2017-11, Vol.120, p.116-125

2017

Volltextzugriff (PDF)

Wind Energy to the Rescue of Mankind from the Menace of the Fossil Fuel Burning Hazards

Wind Power for the World, 2013, p.95-104

2013

Volltextzugriff (PDF)

Prospects and status of non-grid-connected wind power all over the world

2010 World Non-Grid-Connected Wind Power and Energy Conference, 2010, p.1-3

Kane, A

2010

Volltextzugriff (PDF)

Key parameters to be optimized in the development and manufacturing of oral solid-dosage forms

Pharmaceutical Technology, 2017-04, Vol.41 (4), p.18

Kane, Anil

2017

Volltextzugriff (PDF)

Phase-Appropriate Formulation and Process Design

Pharmaceutical Technology, 2016-01, Vol.40 (1), p.42

Kane, Anil

2016

Volltextzugriff (PDF)

Phase-appropriate formulation and process design: appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development

Pharmaceutical technology (2003), 2016-01, p.42

Kane, Anil

2016

Volltextzugriff (PDF)

API properties--risk assessment for effective phase I dosage form development decisions

Pharmaceutical processing, 2015-07, Vol.32 (6), p.22

Kane, Anil

2015

Volltextzugriff (PDF)

Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer

The New England journal of medicine, 2015-08, Vol.373 (6), p.521-529

2015

Volltextzugriff (PDF)

Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis

American Journal of Psychiatry, 2019-01, Vol.176 (1), p.21-28

2019

Volltextzugriff (PDF)

Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia

JAMA psychiatry (Chicago, Ill.), 2015-01, Vol.72 (1), p.5

2015

Volltextzugriff (PDF)

Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study

The American journal of psychiatry, 2015-01, Vol.172 (1), p.52-58

2015

Volltextzugriff (PDF)

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

The international journal of neuropsychopharmacology, 2013-07, Vol.16 (6), p.1205-1218

2013

Volltextzugriff (PDF)

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

JAMA : the journal of the American Medical Association, 2009-10, Vol.302 (16), p.1765

2009

Volltextzugriff (PDF)

Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a consensus?

Oral oncology, 2024-10, Vol.157, p.106972, Article 106972

2024

Volltextzugriff (PDF)

Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia

Proceedings of the National Academy of Sciences - PNAS, 2007-12, Vol.104 (50), p.19942-19947

2007

Volltextzugriff (PDF)

Striatal functional connectivity in psychosis relapse: A hypothesis generating study

Schizophrenia research, 2022-05, Vol.243, p.342-348

2022

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(209)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(225)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(134)
Life Sciences & Biomedicine
(126)
Humans
(102)
Female
(77)
Male
(76)
Adult
(57)
Psychiatry
(49)
Schizophrenia
(47)
Biological And Medical Sciences
(45)
Medical Sciences
(42)
Middle Aged
(35)
Psychology. Psychoanalysis. Psychiatry
(28)
Psychopathology. Psychiatry
(26)
Oncology
(25)
Adolescent
(24)
Adult And Adolescent Clinical Studies
(24)
Psychoses
(24)
Schizophrenia - Drug Therapy
(22)
Neurosciences & Neurology
(20)
Aged
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery

An emerging terpolymeric nanoparticle pore former as an internal recrystallization inhibitor of celecoxib in controlled release amorphous solid dispersion beads: Experimental studies and molecular dynamics analysis

A Quality-by-Design Study for an Immediate-Release Tablet Platform: Examining the Relative Impact of Active Pharmaceutical Ingredient Properties, Processing Methods, and Excipient Variability on Drug Product Quality Attributes

Key parameters to be optimized in the development and manufacturing of oral solid-dosage forms

Phase-Appropriate Formulation and Process Design

Phase-appropriate formulation and process design: appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development

Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: Effect of dosage form design

Tailoring Release Profiles of BCS Class II Drugs Using Controlled Release Amorphous Solid Dispersion Beads with Membrane-Reservoir Design: Effect of Pore Former and Coating Levels

Investigation of a new pH-responsive nanoparticulate pore former for controlled release enteric coating with improved processability and stability

Wind Energy to the Rescue of Mankind from the Menace of the Fossil Fuel Burning Hazards

Prospects and status of non-grid-connected wind power all over the world

Key parameters to be optimized in the development and manufacturing of oral solid-dosage forms

Phase-Appropriate Formulation and Process Design

Phase-appropriate formulation and process design: appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development

API properties--risk assessment for effective phase I dosage form development decisions

Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer

Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia

Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a consensus?

Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia

Striatal functional connectivity in psychosis relapse: A hypothesis generating study

Suchergebnisse filtern